Blog

NEW YORK, NY / ACCESS Newswire / December 5, 2025 / For most companies, visibility arrives when they reinvent themselves. SMX (NASDAQ:SMX) is the rare exception. It didn’t pivot. It didn’t rebrand. It didn’t sprint into the spotlight with a new campaign. It kept building the same core technology, the same infrastructure, and the same thesis it has carried since the beginning. What changed wasn’t SMX. What changed was the world’s ability to see the full picture.

For years, the market tried to place SMX into a neat category. Some saw a sustainability company. Others saw a metals-traceability company. A different group saw a digital-asset data engine. Each interpretation was partially true but incomplete, because SMX never belonged to a single lane. It was always a platform company operating beneath multiple industries that were too disconnected from one another to notice they were solving the same problem. Then those industries began colliding, and the SMX story that once looked fragmented suddenly came into focus.

Molecular Prints in Three Major Sectors
Gold proved to be the first arena where that clarity surfaced. The sector had pushed authenticity as far as paperwork and refinery records could take it. But once gold loses its shape, it loses its story. SMX erased that limitation by embedding identity directly into the metal, giving it a memory that heat and pressure can’t delete. The bullion world realized it now had a path out of centuries of uncertainty. That was one dot on the map.

Sustainability leaders uncovered another. ESG frameworks were tightening, regulations were hardening, and brands were running out of ways to prove recycled content with any degree of credibility. SMX’s molecular marking system stepped in as the missing verification layer. Plastics, textiles, chemicals, and industrial materials could now travel through the circular economy without losing their identity. What had been a reporting challenge became a measurement system. Another dot. Same technology.

Digital ecosystems connected the third. Markets wanted assets tied to real-world performance, not speculation. SMX had already built the bridge. Its Plastic Cycle Token takes verified recovery events and expresses them digitally, using authenticated material data as the source. Suddenly, the same identity system that helped gold speak for itself and helped ESG claims become measurable became the backbone of a new category of digital signals. A third dot. Same system.

What the world missed, until now, was that none of these dots were independent. They formed a pattern. Gold, ESG, and digital assets are not three distant markets. They are three sectors collapsing toward the same requirement: verifiable identity that survives transformation. SMX didn’t build three different solutions. It built one: a molecular identity platform flexible enough to live inside all three arenas without changing its core.

Connecting the Dots
Stakeholders across industries are connecting those dots faster than ever. Refiners see the same integrity engine that regulators see. Global brands see the same verification backbone that digital architects see. Institutions watching the metals world modernize see the same technology powering national circularity programs across Asia. The common thread is not what SMX says. It’s what the technology proves.

That is why the narrative around SMX feels different now. Not because the company changed its trajectory, but because the world finally stopped evaluating it in isolation. SMX’s value doesn’t come from any single vertical. It comes from the way those verticals reinforce one another. Gold’s demand for authenticity strengthens ESG’s demand for transparency. ESG’s demand for transparency creates data that powers the PCT. The PCT creates a digital expression that circles back and elevates the entire platform.

This is the moment where the disconnect disappears. The dots that once looked scattered now form a straight line pointing toward a unified system the market wasn’t ready to recognize, until the pressure across industries forced them to reevaluate what proof actually means.

SMX didn’t change its story. It didn’t have to. The world simply learned how to read it.

About SMX
As global businesses face new and complex challenges relating to carbon neutrality and meeting new governmental and regional regulations and standards, SMX is able to offer players along the value chain access to its marking, tracking, measuring and digital platform technology to transition more successfully to a low-carbon economy.

Forward-Looking Statements
The information in this press release includes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “forecast,” “intends,” “may,” “will,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this press release may include, for example: successful launch and implementation of SMX’s joint projects with manufacturers and other supply chain participants of steel, rubber, plastic and other materials; changes in SMX’s strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects and plans; SMX’s ability to develop and launch new products and services, including its planned Plastic Cycle Token; SMX’s ability to successfully and efficiently integrate future expansion plans and opportunities; SMX’s ability to grow its business in a cost-effective manner; SMX’s product development timeline and estimated research and development costs; the implementation, market acceptance and success of SMX’s business model; developments and projections relating to SMX’s competitors and industry; and SMX’s approach and goals with respect to technology. These forward-looking statements are based on information available as of the date of this press release, and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing views as of any subsequent date, and no obligation is undertaken to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. As a result of a number of known and unknown risks and uncertainties, actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include: the ability to maintain the listing of the Company’s shares on Nasdaq; changes in applicable laws or regulations; the ability to implement business plans, forecasts, and other expectations, and identify and realize additional opportunities; the risk of downturns and the possibility of rapid change in the highly competitive industry in which SMX operates; the risk that SMX and its current and future collaborators are unable to successfully develop and commercialize SMX’s products or services, or experience significant delays in doing so; the risk that the Company may never achieve or sustain profitability; the risk that the Company will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; the risk that the Company experiences difficulties in managing its growth and expanding operations; the risk that third-party suppliers and manufacturers are not able to fully and timely meet their obligations; the risk that SMX is unable to secure or protect its intellectual property; the possibility that SMX may be adversely affected by other economic, business, and/or competitive factors; and other risks and uncertainties described in SMX’s filings from time to time with the Securities and Exchange Commission.

EMAIL: info@securitymattersltd.com

SOURCE: SMX (Security Matters) Public Limited

View the original press release on ACCESS Newswire

ORLANDO, FLORIDA / ACCESS Newswire / December 5, 2025 / RedChip Companies will air interviews with Calidi Biotherapeutics, Inc. (NYSE American:CLDI) and Nova Minerals Limited (Nasdaq:NVA) on the RedChip Small Stocks, Big Money^™ show, a sponsored program on Bloomberg TV this Saturday, December 6, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.

Access the interviews in their entirety at:

• CLDI: https://www.redchip.com/assets/access/cldi_access

• NVA: https://www.redchip.com/assets/access/nva_access

In an exclusive interview, Eric Poma, Ph.D., CEO of Calidi, will appear on the RedChip Small Stocks Big Money^™ show on Bloomberg TV to discuss Calidi’s pioneering approach to precision genetic medicine, enabled by its proprietary RedTail platform-an engineered, systemically delivered viral therapy designed to reach metastatic and difficult-to-treat tumors. The platform cloaks potent genetic payloads, such as IL-15 superagonist, within a human cell-derived envelope, allowing the virus to evade immune detection and find and specifically replicate in tumor cells at metastatic sites. With its scalable, non-integrating viral backbone and ability to deliver multiple genetic payloads, RedTail positions Calidi to address a vast oncology market projected to exceed $560 billion by 2033. The Company is advancing toward IND filing by the end of 2026. Calidi’s capital-efficient business model, strengthened balance sheet, and next-generation pipeline targeting both cancer and autoimmune diseases highlight the Company’s strong potential to deliver value to shareholders.

Christopher Gerteisen, CEO of Nova Minerals, appears on the RedChip Small Stocks Big Money^™ show on Bloomberg TV to outline the Company’s strategy to advance its Estelle Project in Alaska-one of North America’s largest undeveloped gold systems and a rapidly emerging U.S. critical minerals asset. Spanning 514 km² in the world-renowned Tintina Gold Belt, Estelle hosts a 35 km mineralized corridor with more than 20 gold and antimony prospects, including two defined multi-million-ounce gold resources and several drill-ready antimony targets with visible stibnite at surface. Gerteisen will highlight Nova’s dual-pronged development strategy: accelerating its path to becoming a tier-one gold producer while simultaneously establishing the first fully domestic, integrated U.S. antimony supply chain in decades-supported by a transformational US$43.4 million Defense Production Act Title III award from the U.S. Department of War. With military-grade antimony production targeted for 2026/27, active discussions underway with federal agencies and industrial partners, and a feasibility study progressing to expand the current 5.2-million-ounce gold resource, Nova is positioning itself as a strategically vital North American supplier at the intersection of critical minerals security and large-scale gold development.

CLDI and NVA are clients of RedChip Companies. Please read our full disclosure at https://www.redchip.com/legal/disclosures.

About Calidi Biotherapeutics

Calidi Biotherapeutics (NYSE American: CLDI) is a clinical-stage immuno-oncology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal sites of disease. The company’s proprietary Redtail platform features an engineered enveloped oncolytic virus designed for systemic delivery and targeting of metastatic sites. This advanced enveloped technology is intended to shield the virus from immune clearance, allowing virotherapy to effectively reach tumor sites, induce tumor lysis, and deliver potent gene therapies to metastatic locations.

The lead candidate from the Redtail platform, currently in IND-enabling studies, targets non-small cell lung cancer, ovarian cancer, and other tumor types with high unmet medical need. Additionally, Calidi is developing protected virotherapies, in clinical-stage, for intratumoral and localized administration, focusing on a subset of injectable cancer indications.

Calidi Biotherapeutics is headquartered in San Diego, California. For more information, please visit www.calidibio.com.

About Nova Minerals Limited

Nova Minerals Limited is a Gold, Antimony and Critical Minerals exploration and development company focused on advancing the Estelle Project, comprised of 514 km² of State of Alaska mining claims, which contains multiple mining complexes across a 35 km long mineralized corridor of over 20 advanced Gold and Antimony prospects, including two already defined multi-million ounce resources, and several drill ready Antimony prospects with massive outcropping stibnite vein systems observed at surface. The 85% owned project is located 150 km northwest of Anchorage, Alaska, USA, in the prolific Tintina Gold Belt, a province which hosts a >220 million ounce (Moz) documented gold endowment and some of the world’s largest gold mines and discoveries, including Kinross Gold Corporation’s Fort Knox Gold Mine. The belt also hosts significant Antimony deposits and was a historical North American Antimony producer.

Further discussion and analysis of the Estelle Project is available through the interactive Vrify 3D animations, presentations, and videos, all available on the Company’s website. www.novaminerals.com.au

About RedChip Companies

RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on microcap and small-cap companies. Founded in 1992 as a small-cap research firm, RedChip gained early recognition for initiating coverage on emerging blue chip companies such as Apple, Starbucks, Daktronics, Winnebago, and Nike. Over the past 33 years, RedChip has evolved into a full-service investor relations and media firm, delivering concrete, measurable results for its clients, which have included U.S. Steel, Perfumania, Cidara Therapeutics, and Celsius Holdings, among others. Our newsletter, Small Stocks, Big Money^™, is delivered online weekly to 60,000 investors. RedChip has developed the most comprehensive service platform in the industry for microcap and small-cap companies. These services include the following: a worldwide distribution network for its stock research; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated millions of unique investor views; investor webinars and group calls; a television show, Small Stocks, Big Money^™, which airs weekly on Bloomberg US; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more. RedChip also offers RedChat^™, a proprietary AI-powered chatbot that analyzes SEC filings and corporate disclosures for all Nasdaq and NYSE-listed companies, giving investors instant, on-demand insights.

To learn more about RedChip’s products and services, please visit: https://www.redchip.com/corporate/investor_relations

“Discovering Tomorrow’s Blue Chips Today”^™

Follow RedChip on LinkedIn: https://www.linkedin.com/company/redchip/

Follow RedChip on Facebook: https://www.facebook.com/RedChipCompanies

Follow RedChip on Instagram: https://www.instagram.com/redchipcompanies/

Follow RedChip on Twitter: https://twitter.com/RedChip

Follow RedChip on YouTube: https://www.youtube.com/@redchip

Follow RedChip on Rumble: https://rumble.com/c/c-3068340

Subscribe to our Mailing List: https://www.redchip.com/newsletter/latest

Contact:

Dave Gentry
RedChip Companies Inc.
1-800-REDCHIP (733-2447)
1-407-644-4256
info@redchip.com

–END–

SOURCE: RedChip Companies, Inc.

View the original press release on ACCESS Newswire

Funding backs a human-first approach to drug safety and efficacy, reducing reliance on animal testing and accelerating therapies for patients.

NEW HAVEN, CT / ACCESS Newswire / December 5, 2025 / Revalia Bio (Revalia), developer of the Human Data Trial platform, today announced that they are serving as the technical lead for an up to $26.7M contract that they were awarded under the Advanced Research Projects Agency for Health (ARPA-H) Computational ADME-Tox and Physiology Analysis for Safer Therapeutics (CATALYST) program. The project, titled An Integrated Human Data Approach to Unlock the Future of In Silico Learning Models, supports Revalia’s mission to redefine how drug safety and efficacy are predicted before clinical trials.

Revalia will lead the effort to build advanced AI-driven models trained on Human Data Trials, living systems derived from donated human organs, organ-on-chip platforms, and multimodal datasets. The goal is to reduce reliance on animal models and better predict how drugs behave in the human body, cutting costly late-stage failures and accelerating safer therapies.

“This award is a turning point for Revalia and for the broader field of human-based trials,” said Greg Tietjen, PhD, CEO and Co-Founder of Revalia. “It’s a validation for us that confirms that the era for human data is here. Donated human organs are the Rosetta Stone of human-centered development, and our Human Data Trials platform transforms that gift into actionable insight for safer, more effective drugs. Most importantly, this program allows us to further deliver on our mission to honor the legacy of every donor by turning the loss of one life into knowledge that shapes the future of medicine.”

A Human-First Alternative to Animal Models

The ARPA-H CATALYST program is designed to accelerate safer, faster drug development by enabling more accurate predictions of safety and efficacy in investigational new drugs (INDs). CATALYST is led by ARPA-H Health Science Futures Mission Office Acting Deputy Director Andy Kilianski, Ph.D. Revalia’s integrated approach aligns with recent NIH and FDA initiatives to reduce reliance on animal testing by providing rigorous, clinically grounded human datasets to support regulatory innovation.

“Drugs should be tested in the same biology, from the same patients, they are meant to treat,” said Janet Nikolovski, PhD, Chief Data and Innovation Officer at Revalia. “We are generating a unique, integrated human dataset encompassing everything from high level patient data to organ specific physiology and comprehensive molecular level analyses. These data will train models that we believe will better simulate clinical outcomes and reduce the risk of drug failure in clinical trials. This has the potential to change the paradigm for drug development, bringing better and faster therapies to patients who need them.”

Collaborative Ecosystem: The Human Data Stack

Revalia’s Human Data Trials platform forms the foundation of the company’s broader Human Data Stack, a framework that integrates donor organs, organoids, and organ-on-chip systems into a unified translational system. Revalia will collaborate with a national consortium that brings together:

• A leading engineering research institute developing high-dimensional datasets through advanced platforms.

• A regional nonprofit organization focused on expanding access to organ donation for scientific study.

• An academic research lab specializing in artificial intelligence and machine learning to unlock predictive insights.

• A top 10 pharma company looking to integrate New Approach Methodologies (NAMs) into their standard workflows to accelerate the pace of pre-clinical development

“This project unites clinicians, biologists, engineers, and AI/ML experts to build advanced in silico models of human physiology that predict drug metabolism, pharmacokinetics, and toxicity,” said Nabil Boutagy, PhD, Director of Human Data Trial Operations at Revalia. “By integrating diverse expertise and generating multi-omic data at scale, we aim to cut drug development costs and timelines while guiding optimal dosing for patients.”

ABOUT REVALIA BIO:

Revalia Bio is transforming how new medicines are developed by offering on-demand access to real, functional human data. Built on decades of research in human organ perfusion, Revalia’s platform enables rigorous testing in donated human organs maintained under clinical conditions. This makes it possible to run Human Data Trials – studies that generate trial-quality data on safety, efficacy, and mechanism at any stage of development, before a molecule ever reaches a patient. For more information, visit www.revaliabio.com.

MEDIA CONTACT:

Nina Pfister, MAG PR at E: nina@mooringadvisorygroup.com; P: 781-929-5620

SOURCE: Revalia Bio

View the original press release on ACCESS Newswire

New Institutional Investment Vehicle Expected to Drive Awareness, Liquidity, and Value to Bonk, Inc.’s Treasury

SCOTTSDALE, AZ / ACCESS Newswire / December 5, 2025 / Bonk, Inc. (Nasdaq:BNKK) today welcomed a significant development within the broader BONK ecosystem that directly supports the Company’s strategic objective of building shareholder value through digital asset treasury accumulation.

The Company highlighted the recent launch of the BONK Exchange Traded Product (ETP) by Bitcoin Capital AG on the SIX Swiss Exchange.

Mitchell Rudy (a.k.a. Nom), a BONK core contributor and Board Director, commented on the significance of this development: “The momentum we are seeing is undeniable. The ecosystem is expanding rapidly, and institutional financial rails are being built in the EU to broaden access for investors. Bonk, Inc. is positioned perfectly in the center of this growth. We own the treasury, and we are aggressively expanding our portfolio of revenue-generating infrastructure. As the ecosystem grows, Bonk, Inc. grows.”

Market Validation: The “ETP Effect” on Europe’s Third-Largest Exchange The launch of the BONK ETP on the SIX Swiss Exchange-Switzerland’s largest and Europe’s third-largest stock exchange-represents a critical maturation point. This listing allows investors to buy and sell the BONK digital asset just like traditional stocks, without needing specialized expertise or complex digital wallets.

Bitcoin Capital AG, a Swiss-based issuer known for bridging the gap between traditional finance and digital assets, issued the product. The move is widely seen as a major step in the asset’s progression from its community-driven origins to a respected financial asset.

Marcel Niederberger, CEO of Bitcoin Capital, stated in the launch announcement: “With the Bonk ETP now listed on SIX Swiss Exchange, investing in Bonk has never been easier. Investors don’t need [digital asset] expertise; they can trade Bonk just like any other stock. We’re making community-driven digital assets accessible to everyone, while meeting high security and regulatory standards.”

The “Flywheel Effect”: Fueling the Corporate Growth Engine Bonk, Inc. views this third-party development as a direct accelerator for its dual-engine business model. By bridging the gap between traditional finance and the BONK ecosystem, the regulated ETP supports the Company’s growth in two distinct ways:

• Treasury Appreciation: The introduction of a regulated investment vehicle historically lowers barriers for institutional capital. Increased demand and global awareness serve to support the fundamental value of the BONK digital assets held on Bonk, Inc.’s balance sheet.

• Ecosystem Velocity: As the asset gains legitimacy and visibility on global exchanges, it attracts new users and liquidity to the Solana network. This increased activity ultimately drives transaction volume to ecosystem infrastructure like Bonk.fun, where Bonk, Inc. holds a majority revenue interest.

“We are witnessing the rapid maturation of the asset class we have anchored our company to,” added Jarrett Boon, CEO of Bonk, Inc. “The launch of a regulated ETP on a major European market like the SIX Swiss Exchange is a watershed moment. For our shareholders, this is strictly good news. This key institutional on-ramp drives the awareness and activity that ultimately fuels the value of our treasury.”

About Bonk, Inc. Bonk, Inc. (Nasdaq:BNKK) is a company evolving to bridge the gap between traditional public markets and the digital asset ecosystem. Through its subsidiary BONK Holdings LLC, the Company executes a strategy focused on acquiring revenue-generating assets within the DeFi space. The Company also operates a growing beverage division holding the patented Sure Shot and Yerbaé brands.

Investor Relations Contact: Phone: 888.257.8061 Email: investors@bonkdat.com

Forward-Looking Statements: This press release contains forward-looking statements. Such statements are subject to risks and uncertainties, and actual results could differ materially. Factors that could cause or contribute to such differences include, but are not limited to, the performance of BONK digital assets, the adoption of new ecosystem products, market volatility, and other risks detailed in Bonk, Inc.’s filings with the Securities and Exchange Commission.

SOURCE: Bonk, Inc.

View the original press release on ACCESS Newswire

MONROE TOWNSHIP, N.J / ACCESS Newswire / December 5, 2025 / Ocean Power Technologies, Inc. (“OPT” or “the Company”) (NYSE American:OPTT) today announced that it will participate in the DealFlow Discovery Conference, taking place January 28-29, 2026.

Bob Powers, CFO of OPT will deliver a company presentation and be available for one-on-one investor meetings throughout the event. Learn more about OPT at Home – Ocean Power Technologies.

Event Details:

• 3rd Annual DealFlow Discovery Conference

• The Borgata Hotel, Casino & Spa

• Atlantic City, NJ

• January 28-29, 2026

Investors interested in scheduling a meeting with the OPT management team should request an investor pass to attend the conference (no cost to attend).

About OPT

OPT provides intelligent maritime solutions and services that enable safer, cleaner, and more productive ocean operations for the defense and security, oil and gas, science and research, and offshore wind markets, including Merrows™, which provides AI-capable seamless integration of Maritime Domain Awareness Systems across platforms. Our PowerBuoy® platforms provide clean and reliable electric power and real-time data communications for remote maritime and subsea applications. We also provide WAM-V® unmanned surface vehicles (USV’s) and marine robotics services. The Company’s headquarters is located in Monroe Township, New Jersey and has an additional office in Richmond, California. To learn more, visit www.OceanPowerTechnologies.com.

Media Contact:

Bob Powers
CFO
OPT
(609) 730-0400
rpowers@oceanpowertech.com

SOURCE: Ocean Power Technologies, Inc.

View the original press release on ACCESS Newswire

SASKATOON, SASKATCHEWAN / ACCESS Newswire / December 5, 2025 / MAGNUS Construction Services has been recognised with the 2025 Consumer Choice Award in the Insulation Contractor category for Saskatoon. This recognition underscores the company’s leading role in spray foam, thermal, and moisture protection across Saskatchewan.

Proudly family-owned and operated, MAGNUS Construction Services brings over 16 years of experience and a portfolio of more than 7,000 completed residential and commercial projects. Built on a foundation of quality and trust, the team relies on high-performance Canadian products engineered to withstand the region’s demanding prairie climate.

“At MAGNUS, we believe in protecting more than buildings,” says the Magnus Construction Services team. “We safeguard comfort, efficiency, and indoor health-all year long. This award reflects the confidence our clients have in us to get it right every time.”

Tailored Insulation Solutions for Every Project

MAGNUS delivers comprehensive insulation and thermal protection services, tailored to the unique needs of each project:

Residential: Whole-home envelope systems including attic, wall, basement, garage, under slab and foundation spray foam; fiberglass and mineral wool options; air seal,insulation extraction and renovations, drywall, texture and waterproofing services.

Commercial: Thermal barriers, fire-proofing, fire-stopping, high-performance foundation waterproofing systems, flat roof restoration, vapor barriers, drywall, asbestos abatement, and more.

Specialty Projects: Premium Spray Foam and Specialty Coatings for Quonsets, metal buildings, containers, restoration services, and transport applications like custom vans.

Additionally, their spray foam-featuring Insulthane Extreme, best Canadian closed-cell Spray Polyurethane Foam-offers lowest permeability, best dimensional stability, superior R-Value, air and vapour sealing, resistance to mold, pests, and highest overall Thermal Efficiency.

Recognition Rooted in Performance and Professionalism

Winning the Consumer Choice Award reflects MAGNUS’s commitment to excellence and consistent customer satisfaction. Built on dependable workmanship and a safety-first mindset-evident through rigorous employee training and a focus on long-term performance-the award reaffirms their reputation in the community.

Looking Forward with Industry-Leading Standards

As they celebrate the 2025 Consumer Choice Award, MAGNUS’s Construction Services remains dedicated to innovation and quality. By staying ahead with advanced insulation methods and investing in people and training, the company is poised to continue delivering energy-efficient, healthy, and durable environments for Saskatchewan homes and businesses.

To learn more or request a consultation, visit www.magnusconstruction.ca or CLICK HERE.

About MAGNUS’s Construction Services
MAGNUS’s Construction Services is a Saskatoon-based, family-owned provider of moisture and thermal protection solutions. Leveraging over 16 years of experience and more than 7,000 projects, the team delivers tailored, high-performance spray foam, fiberglass, and specialty insulation services across residential, commercial, and unique applications-designed specifically for Saskatchewan’s climate. Learn more at www.magnusconstruction.ca.

About Consumer Choice Award
Consumer Choice Award has been recognizing and promoting business excellence in North America since 1987. Its rigorous selection process ensures that only the most outstanding service providers in each category earn this prestigious recognition. Visit www.ccaward.com to learn more.

Contact Information
Sumi Saleh
Communications Manager
ssaleh@ccaward.com

SOURCE: Consumer Choice Award

View the original press release on ACCESS Newswire